Intestinal microbiota and nonalcoholic steatohepatitis.

about

Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease The Interleukin-20 Cytokine Family in Liver Disease.Emerging concepts in non-invasive monitoring of Crohn's disease.Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma

P2860

Q41552497-9436369A-3BAE-43D3-A4D8-F559D2E3428F Q55233965-7CABF1AC-6815-4CC6-9A9C-3A6BDD5BB41E Q55364545-F3C0AFF3-8E97-464B-B371-B5379EECAF1D Q58693431-FE62BD7C-F1BA-4931-B9F1-6591B3795F5C

P2860

Intestinal microbiota and nonalcoholic steatohepatitis.

Item

http://www.wikidata.org/entity/Q39160020

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Intestinal microbiota and nonalcoholic steatohepatitis.

@en

Intestinal microbiota and nonalcoholic steatohepatitis.

@nl

type

Item

label

Intestinal microbiota and nonalcoholic steatohepatitis.

@en

Intestinal microbiota and nonalcoholic steatohepatitis.

@nl

prefLabel

Intestinal microbiota and nonalcoholic steatohepatitis.

@en

Intestinal microbiota and nonalcoholic steatohepatitis.

@nl

P1476

Intestinal microbiota and nonalcoholic steatohepatitis.

@en

P2093

Bernd Schnabl

http://www.w3.org/2001/XMLSchema#string

P2860

Human gut microbiome viewed across age and geography

An obesity-associated gut microbiome with increased capacity for energy harvest

Molecular Pathogenesis of NASH

The gut microbiota as an environmental factor that regulates fat storage

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

Diet rapidly and reproducibly alters the human gut microbiome

Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability.

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

P304

128-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MOG.0000000000000349

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Katharina Brandl

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28257306

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

5662009

http://www.w3.org/2001/XMLSchema#string

Intestinal microbiota and nonalcoholic steatohepatitis.

about

P2860

P2860

Intestinal microbiota and nonalcoholic steatohepatitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932